Skip to main content

Aadi Bioscience, Inc. (AADI)

NASDAQ: AADI · IEX Real-Time Price · USD
2.02
-0.08 (-3.81%)
At close: Dec 29, 2023, 4:00 PM
2.03
0.00 (0.25%)
After-hours: Dec 29, 2023, 7:24 PM EST

Aadi Bioscience Revenue

Aadi Bioscience had revenue of $23.26M in the twelve months ending September 30, 2023, with 111.62% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $5.96M with 40.38% year-over-year growth. In the year 2022, Aadi Bioscience had annual revenue of $15.22M with 1,258.57% growth.

Revenue (ttm)
$23.26M
Revenue Growth
+111.62%
P/S Ratio
2.13
Revenue / Employee
$264,261
Employees
88
Market Cap
49.54M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202215.22M14.10M
1,258.57%
Dec 31, 20211.12M-13.46M
-92.32%
Dec 31, 202014.58M--
Dec 31, 20190--
Dec 31, 201820.16M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Concord Medical Services Holdings 84.58M
Cryo-Cell International 31.23M
Aligos Therapeutics 16.39M
Marker Therapeutics 9.06M
Cardio Diagnostics Holdings 12.71K
Revenue Rankings

AADI News

More News